Document Detail

Postpartum contraceptive use among adolescent mothers.
MedLine Citation:
PMID:  10775745     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To compare the incidence of repeat pregnancy and method continuation rate at 12 months postpartum in young women who chose either depot medroxyprogesterone acetate or oral contraceptives (OCs) as contraception. METHODS: We conducted a prospective cohort study of 122 postpartum women younger than 18 years of age who delivered between January 8, 1997 and December 31, 1997. Patients choosing depot medroxyprogesterone acetate (n = 76) and OCs (n = 46) were accrued for 12 months and were followed-up for a minimum of 12 months. Main outcome measures were median contraceptive method continuation and the incidence of repeat pregnancy at 12 months postpartum. RESULTS: There was no difference in mean age at delivery (P =.47), parity (P =.84), or gravidity (P =.78) between depot medroxyprogesterone acetate and OC users. At 12 months postpartum, 27.4% of OC users and 55.3% of depot medroxyprogesterone acetate users were still using contraception. Median time to contraceptive discontinuation was longer for those choosing depot medroxyprogesterone acetate compared with OCs (17.8 vs 7.4 months, respectively, P =.002). The overall incidence of repeat pregnancy at 12 months postpartum was 10.6%. Among OC and depot medroxyprogesterone acetate users, respectively, 24% and 2.6% became pregnant again, producing a relative risk (RR) of 9.09 (95% confidence interval [CI] 2.1, 39.2) for repeat pregnancy among OC users. The mean time to repeat pregnancy (this was reported instead of the median time whenever the pregnancy rate had not reached 50% at the end of the follow-up period) was longer for depot medroxyprogesterone acetate compared with OC users (17.1 months vs 13.2 months, respectively, P <.001). CONCLUSION: Adolescent mothers using depot medroxyprogesterone acetate injection for contraception have a higher method continuation rate and a lower incidence of repeat pregnancy at 12 months postpartum than those selecting OCs during the same period.
C L Templeman; V Cook; L J Goldsmith; J Powell; S P Hertweck
Related Documents :
12002445 - Preclinical evaluation of sodium cellulose sulfate (ushercell) as a contraceptive antim...
18320135 - Pregnant woman and road safety: experimental crash test with post mortem human subject.
8739515 - Beliefs about depo-provera among three groups of contraceptors.
7468105 - Study of a new intrauterine device, the multiload 250 cu.
9532995 - Increase in incidence of gastroschisis in the south west of england in 1995.
8823975 - A case of acute respiratory failure in pregnancy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  95     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2000 May 
Date Detail:
Created Date:  2000-05-22     Completed Date:  2000-05-22     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  770-6     Citation Subset:  AIM; IM    
Division of Pediatric and Adolescent Gynecology, University of Louisville, Louisville, Kentucky 40492, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cohort Studies
Contraception Behavior*
Contraceptive Agents, Female / therapeutic use*
Contraceptives, Oral, Combined / therapeutic use*
Kentucky / epidemiology
Medroxyprogesterone Acetate / therapeutic use*
Patient Compliance
Postpartum Period*
Pregnancy in Adolescence / prevention & control,  statistics & numerical data*
Prospective Studies
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Contraceptives, Oral, Combined; 71-58-9/Medroxyprogesterone Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study.
Next Document:  Nausea and vomiting in early pregnancy: its role in placental development.